We are live on ! Find out more
PA

Parallel Advisors Portfolio holdings

AUM $6.56B
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
+8.88%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.4%
10 Year Est. Return
–
AUM
$5B
AUM Growth
+$569M
Cap. Flow
+$92M
Cap. Flow %
1.84%
Top 10 Hldgs %
38.84%
Holding
3,762
New
250
Increased
1,451
Reduced
1,277
Closed
224

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$18.4M
2
ITOT icon
iShares Core S&P Total US Stock Market ETF
ITOT
+$9.77M
3
DYNF icon
BlackRock US Equity Factor Rotation ETF
DYNF
+$5.48M
4
MSFT icon
Microsoft
MSFT
+$4.93M
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$4.9M

Top Sells

Rank Stock Value
1
CORT icon
Corcept Therapeutics
CORT
+$7.34M
2
SBUX icon
Starbucks
SBUX
+$4.7M
3
CMF icon
iShares California Muni Bond ETF
CMF
+$3.3M
4
RSP icon
Invesco S&P 500 Equal Weight ETF
RSP
+$2.63M
5
VB icon
Vanguard Morningstar Small-Cap ETF
VB
+$1.7M

Sector Composition

Rank Sector Weight
1 Technology 17.21%
2 Healthcare 9.68%
3 Financials 7.2%
4 Communication Services 5.16%
5 Consumer Discretionary 4.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ASTE icon
3251
Astec Industries
ASTE
$1.02B
$625 ﹤0.01%
15
-63
-81% -$2.39K
TEM
3252
Tempus AI
TEM
$9.39B
$625 ﹤0.01%
10
– –
WVE icon
3253
Wave Life Sciences
WVE
$1.2B
$618 ﹤0.01%
95
– –
SEGG
3254
Sports Entertainment Gaming Global Corp
SEGG
$8.25M
$610 ﹤0.01%
7
– –
SLDB icon
3255
Solid Biosciences
SLDB
$900M
$609 ﹤0.01%
125
+118
+1,686% +$417
CLFD icon
3256
Clearfield
CLFD
$374M
$608 ﹤0.01%
14
– –
SEM
3257
DELISTED
Select Medical
SEM
$607 ﹤0.01%
40
+32
+400% +$499
GUNR icon
3258
FlexShares Global Upstream Natural Resources Index Fund
GUNR
$6.97B
$602 ﹤0.01%
15
-514
-97% -$19.8K
DYN icon
3259
Dyne Therapeutics
DYN
$4.9B
$590 ﹤0.01%
62
+35
+130% +$385
EQX icon
3260
Equinox Gold
EQX
$13.5B
$581 ﹤0.01%
101
-2,600
-96% -$16.9K
VTVT icon
3261
vTv Therapeutics
VTVT
$139M
$570 ﹤0.01%
38
– –
RAPP
3262
Rapport Therapeutics
RAPP
$2.18B
$569 ﹤0.01%
+50
New +$531
ATEX icon
3263
Anterix
ATEX
$1.94B
$564 ﹤0.01%
22
-61
-73% -$1.78K
RCKT icon
3264
Rocket Pharmaceuticals
RCKT
$394M
$564 ﹤0.01%
230
-802
-78% -$4.06K
ELVN icon
3265
Enliven Therapeutics
ELVN
$4.43B
$562 ﹤0.01%
28
+18
+180% +$341
HIPO icon
3266
Hippo Holdings
HIPO
$861M
$559 ﹤0.01%
20
-75
-79% -$1.85K
AFCG
3267
AFC Gamma
AFCG
$63.4M
$556 ﹤0.01%
124
– –
RGNX icon
3268
Regenxbio
RGNX
$708M
$550 ﹤0.01%
67
+17
+34% +$142
DSGR icon
3269
Distribution Solutions Group
DSGR
$1.61B
$549 ﹤0.01%
20
– –
GDOT icon
3270
Green Dot
GDOT
$745M
$547 ﹤0.01%
+51
New +$461
NPKI
3271
NPK International
NPKI
$1.14B
$528 ﹤0.01%
+62
New +$454
LZ icon
3272
LegalZoom.com
LZ
$988M
$526 ﹤0.01%
59
-48
-45% -$402
PAX icon
3273
Patria Investments
PAX
$1.86B
$506 ﹤0.01%
36
-241
-87% -$2.89K
AURA icon
3274
Aura Biosciences
AURA
$826M
$495 ﹤0.01%
+79
New +$462
GETY icon
3275
Getty Images
GETY
$183M
$493 ﹤0.01%
297
-270
-48% -$476
129 130
131
132 133

Similar funds

HFS
Hantz Financial Services Southfield, Michigan $6.56B AUM 16.11% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
LAM
Lyrical Asset Management New York $6.56B AUM 20.06% 1-Year Est. Return
BF
BOK Financial Tulsa, Oklahoma $6.54B AUM 25.41% 1-Year Est. Return
NMIMC
Northwestern Mutual Investment Management Company Milwaukee, Wisconsin $6.6B AUM 19.75% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Parallel Advisors's Q2 2025 Portfolio in Review

As of Q2 2025, Parallel Advisors held 3,762 positions worth $5B, up 13% from $4.43B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Parallel Advisors's Q2 2025 filing shows 250 new, 1,451 increased, 1,277 reduced and 224 closed positions. Its largest new stake was Vanguard 0-3 Month Treasury Bill ETF: 32,722 shares worth $2.47M. The largest sale was Corcept Therapeutics, an estimated $7.34M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.

  • Parallel Advisors's largest Q2 2025 buy was Vanguard 0-3 Month Treasury Bill ETF: 32,722 shares worth $2.47M.
  • Parallel Advisors added most to iShares Core S&P 500 ETF in Q2 2025, an estimated $18.4M increase.
  • Parallel Advisors's biggest Q2 2025 reduction was Corcept Therapeutics, cutting an estimated $7.34M.
  • Parallel Advisors fully exited Discover Financial Services in Q2 2025, selling an estimated $1.22M.
  • Parallel Advisors's ten largest holdings make up 39% of its $5B portfolio in Q2 2025.
  • Parallel Advisors opened 250 new positions and closed 224 in Q2 2025.
  • Parallel Advisors's portfolio value rose 13% quarter-over-quarter to $5B.

Based on Parallel Advisors's 13F filing for Q2 2025, filed 8 Jul 2025.